Singapore: The annual revenue for biopharmaceuticals has been consistently growing since 2001, accounting for 15.6 perc...
India, which has the second largest population in the world and is among the top three nations in terms of patient pool,...
Singapore: Cadila Healthcare, India Chairman: Mr Pankaj R PatelRevenue: $1285.6 mnBusiness: Discovery, development, m...
Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compo...
Singapore: India has maintained its lead over China in terms of pharma exports, according to a statement by the ministry...
Singapore: LifeCell International, India's largest stem cell storage company, announced the launch of India's first Dual...
Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...
For more than 135 years, Eli Lilly and Company has demonstrated a commitment to be a responsible global citizen, in larg...
Singapore: European Commission president Mr José Manuel Barroso, and Commissioner for Research, Innovation and Scienc...
Singapore: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food &...
Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate ...
Singapore: Pharma Major, Lupin Limited announced today that it has entered into a strategic joint venture agreement with...
As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more com...
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...
Singapore: With a view to make medicines for critical diseases more affordable, India's National Pharmaceutical Pricing ...
Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed a...
Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-b...
US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...
